Project Budget Planning
Purpose
This document is a forecast of the projects planned by the product development department, which is comprised of many teams. It is intended to be used for planning grants and funding applications.
Projects
Timeline
Financial Forecast
This cash flow forecast shows monthly budget allocation across all projects. Each task's cost is placed in its start month, with totals displayed by month, quarter, and year.
Department
Priority
| Tasks | Q1 Mar 2024 | Q2 Apr 2024 | Q2 May 2024 | Q2 Jun 2024 | Q3 Jul 2024 | Q3 Aug 2024 | Q3 Sep 2024 | Q4 Oct 2024 | Q4 Nov 2024 | Q4 Dec 2024 | Q1 Jan 2025 | Q1 Feb 2025 | Q1 Mar 2025 | Q2 Apr 2025 | Q2 May 2025 | Q2 Jun 2025 | Q3 Jul 2025 | Q3 Aug 2025 | Q3 Sep 2025 | Q4 Oct 2025 | Q4 Nov 2025 | Q4 Dec 2025 | Q1 Jan 2026 | Q1 Feb 2026 | Q1 Mar 2026 | Q2 Apr 2026 | Q2 May 2026 | Q2 Jun 2026 | Q3 Jul 2026 | Q3 Aug 2026 | Q3 Sep 2026 | Q4 Oct 2026 | Q4 Nov 2026 | Q4 Dec 2026 | Q1 Jan 2027 | Q1 Feb 2027 | Q1 Mar 2027 | Q2 Apr 2027 | Q2 May 2027 | Q2 Jun 2027 | Q3 Jul 2027 | Q3 Aug 2027 | Q3 Sep 2027 | Q4 Oct 2027 | Q4 Nov 2027 | Q4 Dec 2027 | Q1 Jan 2028 | 2024-Q1 | 2024-Q2 | 2024-Q3 | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 | 2026-Q3 | 2026-Q4 | 2027-Q1 | 2027-Q2 | 2027-Q3 | 2027-Q4 | 2028-Q1 | 2024 | 2025 | 2026 | 2027 | 2028 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ▶Clinical Evidence | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | €1,000 | - | €2,181 | - | - | €165,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | €3,181 | €165,000 | - | - | - | - | - | - | - | - | - | €168,181 | - | - | €168,181 |
| ▶Medical Data Science | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | €186,613 | - | - | - | - | €11,823 | - | - | €114,335 | - | - | - | - | - | - | €7,998 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | €186,613 | €11,823 | €114,335 | - | - | €7,998 | - | - | - | - | - | €312,771 | €7,998 | - | €320,768 |
| ▶Other Software Development | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | €227,000 | - | - | €60,000 | - | €45,000 | - | €20,000 | €37,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | €227,000 | €105,000 | €57,000 | - | - | - | - | - | - | - | - | €389,000 | - | - | €389,000 |
| ▶Regulatory and Compliance | €129,180 | - | - | €4,482 | - | - | €242,882 | - | - | €6,898 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | €129,180 | €4,482 | €242,882 | €6,898 | - | - | - | - | - | - | - | - | - | - | - | - | - | €383,442 | - | - | - | - | €383,442 |
| TOTAL | €129,180 | - | - | €4,482 | - | - | €242,882 | - | - | €6,898 | - | - | - | - | - | - | - | - | - | - | - | - | €414,613 | - | €2,181 | €60,000 | - | €221,823 | - | €20,000 | €151,335 | - | - | - | - | - | - | €7,998 | - | - | - | - | - | - | - | - | - | €129,180 | €4,482 | €242,882 | €6,898 | - | - | - | - | €416,794 | €281,823 | €171,335 | - | - | €7,998 | - | - | - | €383,442 | - | €869,952 | €7,998 | - | €1,261,392 |
| CUMULATIVE | €129,180 | €129,180 | €129,180 | €133,662 | €133,662 | €133,662 | €376,544 | €376,544 | €376,544 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €798,055 | €798,055 | €800,236 | €860,236 | €860,236 | €1,082,060 | €1,082,060 | €1,102,060 | €1,253,394 | €1,253,394 | €1,253,394 | €1,253,394 | €1,253,394 | €1,253,394 | €1,253,394 | €1,261,392 | €1,261,392 | €1,261,392 | €1,261,392 | €1,261,392 | €1,261,392 | €1,261,392 | €1,261,392 | €1,261,392 | €1,261,392 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | €1,261,392 |
Spending by Department
This pie chart visualizes the distribution of budget across different departments.
Task Spending Breakdown
This bar chart shows individual tasks ranked by their spending amounts, providing insight into which tasks require the most budget.
Showing top 30 tasks by spending amount (descending order). Labels show task IDs only.
Hiring Requirements
This section shows all tasks that require hiring new employees, including estimated hours and costs.
| Department | Project | Task | Hours Required | Adjusted Hours | Start Date |
|---|---|---|---|---|---|
| Other Software Development | DEV-K7X Development of the clinical trial application | DEV-K7X-02 Improve backend performance and scaling initiative | 150hrs | 75hrs | Jan 1, 2026 |
| Other Software Development | DEV-K7X Development of the clinical trial application | AP-08 Partner API integration enablement | 800hrs | 400hrs | Jan 1, 2026 |
| Other Software Development | DEV-9BR Medical device maintenance and minor enhancements | DEV-9BR-03 Infrastructure resilience project | 640hrs | 320hrs | Jan 1, 2026 |
| Other Software Development | DEV-9BR Medical device maintenance and minor enhancements | DEV-9BR-04 Integration support & SDKs | 560hrs | 280hrs | Jan 1, 2026 |
| Other Software Development | DEV-X9C Make the medical device FHIR compliant | DEV-X9C-02 FHIR implementation | 200hrs | 100hrs | Sep 1, 2026 |
| Other Software Development | DEV-5LP Establish unified data insights and analytics capabilities | DEV-5LP-01 Unify the data ingestion pipeline | 200hrs | 100hrs | Jan 1, 2026 |
| Other Software Development | DEV-W8Z Optimize and enhance internal software tools and applications | DEV-W8Z-01 Maintain the internal applications: web, QMS, CVAT... | 80hrs | 40hrs | Jan 1, 2026 |
| TOTAL (7 tasks) | 2,630 | 1,315 | |||
Monthly Hiring Timeline
Shows when employees are needed (starts) and when they become available for reassignment (ends)
| Month | New Hires | Available | Net Change | Cumulative | Tasks |
|---|---|---|---|---|---|
| Jan 2026 | +0.56 | +0.56 | 0.56 FTE | DEV-K7X-02, AP-08, DEV-9BR-03, DEV-9BR-04, DEV-5LP-01, DEV-W8Z-01 | |
| Sep 2026 | +0.19 | +0.19 | 0.75 FTE | DEV-X9C-02 | |
| Dec 2026 | -0.19 | -0.19 | 0.56 FTE | Ending: DEV-X9C-02 | |
| Jan 2027 | -0.53 | -0.53 | 0.03 FTE | Ending: DEV-K7X-02, AP-08, DEV-9BR-03, DEV-9BR-04, DEV-W8Z-01 | |
| Jul 2027 | -0.03 | -0.03 | 0.00 FTE | Ending: DEV-5LP-01 |
Hiring Needs by Department
Detailed project list
EU CE Marking and ISO 13485 Maintenance
[REG-03]HIGHAchieve and maintain CE Mark certification under the MDR/MDD framework, including all required audits and technical file reviews.
Annual Market Access Renewals
[REG-05]MEDIUMMandatory annual fees for renewing licenses, registrations, and authorized representative services to maintain market access.
FDA 510(k) Clearance and US Expansion
[REG-02]HIGHExecute regulatory submission, consultant support, and mandated human factors and cybersecurity testing for US market access.
QMS and Security Certification
[REG-04]HIGHAchieve and maintain crucial security and quality management system certifications (ISO 27001, ENS, ISO 13485).
Brazil ANVISA Market Access
[REG-01]HIGHEstablish regulatory compliance and maintain required infrastructure fees for placing the device on the Brazilian market.
Diagnosis support AI model improvement
[MDS-01]HIGHEnhance the diagnosis support model specially in - Inflammatory lesions (teladoc, all clients) - Sarna (SESPA, visiba, all clients) - Burns
Develop an advanced image qualification algorithm
[MDS-04]MEDIUMThe goal is to create a better initial "filter" of what could be a good or bad image based on DIQA, entropy, non-specific and other parameters. The goal is to ask for another photo at that moment and avoid recieving an out of context or bad quality image
Next-level HS severity assessment
[MDS-06]HIGHThe goal is to improve and market the best as possible our HS algorithms: - AIHS4: improve it - Hurley: create it - Phenotype: market it, not included yet
ASALT: fine-tuning and validation for better performance
[MDS-07]MEDIUMASALT works pretty fine. This scoring systems should work very good as it will be used and sold for clinical trials, so we need to - Expand internal validation beyond Álvaro's labels to better fine-tune the model - Potentially annnotate more images In addition, check limitations like grey hair.
AVASI minor improvements
[MDS-08]LOWAnnotate more data and get it tested on full body
Optimize cloud costs and resource usage for all software products
[DEV-H5N]HIGHImplement cost-saving measures and resource optimization strategies across all cloud-hosted software products to reduce operational expenses while maintaining performance and reliability.
Development of the clinical trial application
[DEV-K7X]MEDIUMMaintenance and enhancements of the clinical trial management web application
Development of the lite application for medical centers, insurance companies, and other healthcare providers
[DEV-J2V]MEDIUMKeep maintaining and improving the lightweight version of our main application tailored for use by medical centers, insurance companies, and other healthcare providers to facilitate easier access and usability.
Create new calculators for specialized scoring systems and pathologies
[DEV-2QM]MEDIUMBuild and maintain specialized web calculators for targeted scoring systems and pathologies.
Medical device maintenance and minor enhancements
[DEV-9BR]HIGHOngoing maintenance and incremental improvements to the medical device software platform, ensuring compliance and performance.
Establish unified data insights and analytics capabilities
[DEV-5LP]MEDIUMUnified data pipelines, advanced analyses, and dashboarding for product & business decisions.
Optimize and enhance internal software tools and applications
[DEV-W8Z]MEDIUMImprove internal software tools to boost productivity, streamline workflows, and enhance data management capabilities across the organization.
Vall d'Hebron Clinical Study 2025
[CLN-02]HIGHClinical validation study at Hospital Universitari Vall d'Hebron
aEASI Hospital Virgen de las Nieves Study
[CLN-01]HIGHPost-Market Clinical Follow-up study for automated EASI scoring system at HVN Granada
Integrate LLM's in frontend applications to provide advanced user assistance and insights
[DEV-7SX]LOWERIncorporate Large Language Models (LLMs) into our frontend applications to enhance user assistance, provide contextual insights, and improve overall user experience.
Create a complete monitoring and alerting system for the medical device
[DEV-3HZ]MEDIUMDevelop a comprehensive monitoring and alerting system to ensure the medical device operates reliably and meets regulatory standards.
PASI/SCORAD minor improvements
[MDS-09]LOWAnnotate more data and get them tested on full body
Obtain ENS or ISO 27001 security certification
[DEV-R4M]HIGHAllocate budget to purchase, configure, and install licenses and services necessary for ENS (Esquema Nacional de Seguridad) or ISO 27001 certification, including SIEM tools, SOAR, IDS/IPS, and WAF solutions.
FDA 510(k) Clearance
[CLN-03]HIGHFDA clearance process including retrospective clinical study analysis
Develop a complete audit logging system for the medical device
[DEV-4TY]MEDIUMCreate an audit logging system to track all user and system activities related to the medical device, ensuring compliance with regulatory requirements.
Diagnosis support: image + language model
[MDS-02]HIGHMore beyond image data to merge other clinical data and improve the output. We could validate on a dataset from Torrejón that they did not start gathering yet.
Expanding ALADIN beyond inflammatory lesions
[MDS-05]HIGHThe goal is to develop a more advanced version of ALADIN that identifies the type of inflammatory lesions and also non-inflammatory lesions
AWOSI
[MDS-10]HIGHAWOSI has a lot of potential in several fields and many pathologies, as it works for any kind of wound, which includes ulcerous pathologies like pyoderma cangrenosum
Add more languages to the different software products
[DEV-J4P]MEDIUMExpand the language support of our software products to reach a broader audience and improve user experience for non-English speakers.
Integrate lightweight AI models for on-device image analysis
[DEV-6NW]LOWERIncorporate optimized AI models that can run directly on user devices to provide real-time image analysis without needing constant internet connectivity.
Make the medical device FHIR compliant
[DEV-X9C]HIGHImplement FHIR standards in the medical device to ensure interoperability with other healthcare systems and compliance with industry regulations.
Add more binary indicators
[MDS-03]LOWCreate more binary indicators, like malignancy and urgency, that could be useful for clinical workflows
Projects by department
Regulatory and Compliance
This cash flow forecast shows monthly budget allocation across all projects. Each task's cost is placed in its start month, with totals displayed by month, quarter, and year.
| Tasks | Q1 Mar 2024 | Q2 Apr 2024 | Q2 May 2024 | Q2 Jun 2024 | Q3 Jul 2024 | Q3 Aug 2024 | Q3 Sep 2024 | Q4 Oct 2024 | Q4 Nov 2024 | Q4 Dec 2024 | Q1 Jan 2025 | Q1 Feb 2025 | Q1 Mar 2025 | Q2 Apr 2025 | Q2 May 2025 | Q2 Jun 2025 | Q3 Jul 2025 | Q3 Aug 2025 | Q3 Sep 2025 | Q4 Oct 2025 | Q4 Nov 2025 | Q4 Dec 2025 | Q1 Jan 2026 | Q1 Feb 2026 | Q1 Mar 2026 | Q2 Apr 2026 | Q2 May 2026 | Q2 Jun 2026 | Q3 Jul 2026 | Q3 Aug 2026 | Q3 Sep 2026 | Q4 Oct 2026 | Q4 Nov 2026 | Q4 Dec 2026 | Q1 Jan 2027 | Q1 Feb 2027 | Q1 Mar 2027 | Q2 Apr 2027 | Q2 May 2027 | Q2 Jun 2027 | Q3 Jul 2027 | Q3 Aug 2027 | Q3 Sep 2027 | Q4 Oct 2027 | Q4 Nov 2027 | Q4 Dec 2027 | 2024-Q1 | 2024-Q2 | 2024-Q3 | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 | 2026-Q3 | 2026-Q4 | 2027-Q1 | 2027-Q2 | 2027-Q3 | 2027-Q4 | 2024 | 2025 | 2026 | 2027 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ▶Regulatory and Compliance | €129,180 | - | - | €4,482 | - | - | €242,882 | - | - | €6,898 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | €129,180 | €4,482 | €242,882 | €6,898 | - | - | - | - | - | - | - | - | - | - | - | - | €383,442 | - | - | - | €383,442 |
| TOTAL | €129,180 | - | - | €4,482 | - | - | €242,882 | - | - | €6,898 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | €129,180 | €4,482 | €242,882 | €6,898 | - | - | - | - | - | - | - | - | - | - | - | - | €383,442 | - | - | - | €383,442 |
| CUMULATIVE | €129,180 | €129,180 | €129,180 | €133,662 | €133,662 | €133,662 | €376,544 | €376,544 | €376,544 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | €383,442 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | €383,442 |
This bar chart shows individual tasks ranked by their spending amounts, providing insight into which tasks require the most budget.
Showing top 30 tasks by spending amount (descending order). Labels show task IDs only.
EU CE Marking and ISO 13485 Maintenance
[REG-03]HIGHAchieve and maintain CE Mark certification under the MDR/MDD framework, including all required audits and technical file reviews.
Annual Market Access Renewals
[REG-05]MEDIUMMandatory annual fees for renewing licenses, registrations, and authorized representative services to maintain market access.
FDA 510(k) Clearance and US Expansion
[REG-02]HIGHExecute regulatory submission, consultant support, and mandated human factors and cybersecurity testing for US market access.
QMS and Security Certification
[REG-04]HIGHAchieve and maintain crucial security and quality management system certifications (ISO 27001, ENS, ISO 13485).
Brazil ANVISA Market Access
[REG-01]HIGHEstablish regulatory compliance and maintain required infrastructure fees for placing the device on the Brazilian market.
Medical Data Science
This cash flow forecast shows monthly budget allocation across all projects. Each task's cost is placed in its start month, with totals displayed by month, quarter, and year.
| Tasks | Q1 Jan 2026 | Q1 Feb 2026 | Q1 Mar 2026 | Q2 Apr 2026 | Q2 May 2026 | Q2 Jun 2026 | Q3 Jul 2026 | Q3 Aug 2026 | Q3 Sep 2026 | Q4 Oct 2026 | Q4 Nov 2026 | Q4 Dec 2026 | Q1 Jan 2027 | Q1 Feb 2027 | Q1 Mar 2027 | Q2 Apr 2027 | Q2 May 2027 | Q2 Jun 2027 | Q3 Jul 2027 | Q3 Aug 2027 | Q3 Sep 2027 | Q4 Oct 2027 | Q4 Nov 2027 | Q4 Dec 2027 | Q1 Jan 2028 | 2026-Q1 | 2026-Q2 | 2026-Q3 | 2026-Q4 | 2027-Q1 | 2027-Q2 | 2027-Q3 | 2027-Q4 | 2028-Q1 | 2026 | 2027 | 2028 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ▶Medical Data Science | €186,613 | - | - | - | - | €11,823 | - | - | €114,335 | - | - | - | - | - | - | €7,998 | - | - | - | - | - | - | - | - | - | €186,613 | €11,823 | €114,335 | - | - | €7,998 | - | - | - | €312,771 | €7,998 | - | €320,768 |
| TOTAL | €186,613 | - | - | - | - | €11,823 | - | - | €114,335 | - | - | - | - | - | - | €7,998 | - | - | - | - | - | - | - | - | - | €186,613 | €11,823 | €114,335 | - | - | €7,998 | - | - | - | €312,771 | €7,998 | - | €320,768 |
| CUMULATIVE | €186,613 | €186,613 | €186,613 | €186,613 | €186,613 | €198,436 | €198,436 | €198,436 | €312,771 | €312,771 | €312,771 | €312,771 | €312,771 | €312,771 | €312,771 | €320,768 | €320,768 | €320,768 | €320,768 | €320,768 | €320,768 | €320,768 | €320,768 | €320,768 | €320,768 | - | - | - | - | - | - | - | - | - | - | - | - | €320,768 |
This bar chart shows individual tasks ranked by their spending amounts, providing insight into which tasks require the most budget.
Showing top 30 tasks by spending amount (descending order). Labels show task IDs only.
Diagnosis support AI model improvement
[MDS-01]HIGHEnhance the diagnosis support model specially in - Inflammatory lesions (teladoc, all clients) - Sarna (SESPA, visiba, all clients) - Burns
Develop an advanced image qualification algorithm
[MDS-04]MEDIUMThe goal is to create a better initial "filter" of what could be a good or bad image based on DIQA, entropy, non-specific and other parameters. The goal is to ask for another photo at that moment and avoid recieving an out of context or bad quality image
Next-level HS severity assessment
[MDS-06]HIGHThe goal is to improve and market the best as possible our HS algorithms: - AIHS4: improve it - Hurley: create it - Phenotype: market it, not included yet
ASALT: fine-tuning and validation for better performance
[MDS-07]MEDIUMASALT works pretty fine. This scoring systems should work very good as it will be used and sold for clinical trials, so we need to - Expand internal validation beyond Álvaro's labels to better fine-tune the model - Potentially annnotate more images In addition, check limitations like grey hair.
AVASI minor improvements
[MDS-08]LOWAnnotate more data and get it tested on full body
PASI/SCORAD minor improvements
[MDS-09]LOWAnnotate more data and get them tested on full body
Diagnosis support: image + language model
[MDS-02]HIGHMore beyond image data to merge other clinical data and improve the output. We could validate on a dataset from Torrejón that they did not start gathering yet.
Expanding ALADIN beyond inflammatory lesions
[MDS-05]HIGHThe goal is to develop a more advanced version of ALADIN that identifies the type of inflammatory lesions and also non-inflammatory lesions
AWOSI
[MDS-10]HIGHAWOSI has a lot of potential in several fields and many pathologies, as it works for any kind of wound, which includes ulcerous pathologies like pyoderma cangrenosum
Add more binary indicators
[MDS-03]LOWCreate more binary indicators, like malignancy and urgency, that could be useful for clinical workflows
Other Software Development
This cash flow forecast shows monthly budget allocation across all projects. Each task's cost is placed in its start month, with totals displayed by month, quarter, and year.
| Tasks | Q1 Jan 2026 | Q1 Feb 2026 | Q1 Mar 2026 | Q2 Apr 2026 | Q2 May 2026 | Q2 Jun 2026 | Q3 Jul 2026 | Q3 Aug 2026 | Q3 Sep 2026 | Q4 Oct 2026 | Q4 Nov 2026 | Q4 Dec 2026 | Q1 Jan 2027 | Q1 Feb 2027 | Q1 Mar 2027 | Q2 Apr 2027 | Q2 May 2027 | Q2 Jun 2027 | Q3 Jul 2027 | 2026-Q1 | 2026-Q2 | 2026-Q3 | 2026-Q4 | 2027-Q1 | 2027-Q2 | 2027-Q3 | 2026 | 2027 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ▶Other Software Development | €227,000 | - | - | €60,000 | - | €45,000 | - | €20,000 | €37,000 | - | - | - | - | - | - | - | - | - | - | €227,000 | €105,000 | €57,000 | - | - | - | - | €389,000 | - | €389,000 |
| TOTAL | €227,000 | - | - | €60,000 | - | €45,000 | - | €20,000 | €37,000 | - | - | - | - | - | - | - | - | - | - | €227,000 | €105,000 | €57,000 | - | - | - | - | €389,000 | - | €389,000 |
| CUMULATIVE | €227,000 | €227,000 | €227,000 | €287,000 | €287,000 | €332,000 | €332,000 | €352,000 | €389,000 | €389,000 | €389,000 | €389,000 | €389,000 | €389,000 | €389,000 | €389,000 | €389,000 | €389,000 | €389,000 | - | - | - | - | - | - | - | - | - | €389,000 |
This bar chart shows individual tasks ranked by their spending amounts, providing insight into which tasks require the most budget.
Showing top 30 tasks by spending amount (descending order). Labels show task IDs only.
Optimize cloud costs and resource usage for all software products
[DEV-H5N]HIGHImplement cost-saving measures and resource optimization strategies across all cloud-hosted software products to reduce operational expenses while maintaining performance and reliability.
Development of the clinical trial application
[DEV-K7X]MEDIUMMaintenance and enhancements of the clinical trial management web application
Development of the lite application for medical centers, insurance companies, and other healthcare providers
[DEV-J2V]MEDIUMKeep maintaining and improving the lightweight version of our main application tailored for use by medical centers, insurance companies, and other healthcare providers to facilitate easier access and usability.
Create new calculators for specialized scoring systems and pathologies
[DEV-2QM]MEDIUMBuild and maintain specialized web calculators for targeted scoring systems and pathologies.
Medical device maintenance and minor enhancements
[DEV-9BR]HIGHOngoing maintenance and incremental improvements to the medical device software platform, ensuring compliance and performance.
Establish unified data insights and analytics capabilities
[DEV-5LP]MEDIUMUnified data pipelines, advanced analyses, and dashboarding for product & business decisions.
Optimize and enhance internal software tools and applications
[DEV-W8Z]MEDIUMImprove internal software tools to boost productivity, streamline workflows, and enhance data management capabilities across the organization.
Integrate LLM's in frontend applications to provide advanced user assistance and insights
[DEV-7SX]LOWERIncorporate Large Language Models (LLMs) into our frontend applications to enhance user assistance, provide contextual insights, and improve overall user experience.
Create a complete monitoring and alerting system for the medical device
[DEV-3HZ]MEDIUMDevelop a comprehensive monitoring and alerting system to ensure the medical device operates reliably and meets regulatory standards.
Obtain ENS or ISO 27001 security certification
[DEV-R4M]HIGHAllocate budget to purchase, configure, and install licenses and services necessary for ENS (Esquema Nacional de Seguridad) or ISO 27001 certification, including SIEM tools, SOAR, IDS/IPS, and WAF solutions.
Develop a complete audit logging system for the medical device
[DEV-4TY]MEDIUMCreate an audit logging system to track all user and system activities related to the medical device, ensuring compliance with regulatory requirements.
Add more languages to the different software products
[DEV-J4P]MEDIUMExpand the language support of our software products to reach a broader audience and improve user experience for non-English speakers.
Integrate lightweight AI models for on-device image analysis
[DEV-6NW]LOWERIncorporate optimized AI models that can run directly on user devices to provide real-time image analysis without needing constant internet connectivity.
Make the medical device FHIR compliant
[DEV-X9C]HIGHImplement FHIR standards in the medical device to ensure interoperability with other healthcare systems and compliance with industry regulations.
Clinical Evidence
This cash flow forecast shows monthly budget allocation across all projects. Each task's cost is placed in its start month, with totals displayed by month, quarter, and year.
| Tasks | Q1 Jan 2026 | Q1 Feb 2026 | Q1 Mar 2026 | Q2 Apr 2026 | Q2 May 2026 | Q2 Jun 2026 | Q3 Jul 2026 | Q3 Aug 2026 | Q3 Sep 2026 | Q4 Oct 2026 | Q4 Nov 2026 | Q4 Dec 2026 | Q1 Jan 2027 | Q1 Feb 2027 | Q1 Mar 2027 | Q2 Apr 2027 | Q2 May 2027 | Q2 Jun 2027 | Q3 Jul 2027 | Q3 Aug 2027 | Q3 Sep 2027 | 2026-Q1 | 2026-Q2 | 2026-Q3 | 2026-Q4 | 2027-Q1 | 2027-Q2 | 2027-Q3 | 2026 | 2027 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ▶Clinical Evidence | €1,000 | - | €2,181 | - | - | €165,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | €3,181 | €165,000 | - | - | - | - | - | €168,181 | - | €168,181 |
| TOTAL | €1,000 | - | €2,181 | - | - | €165,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | €3,181 | €165,000 | - | - | - | - | - | €168,181 | - | €168,181 |
| CUMULATIVE | €1,000 | €1,000 | €3,181 | €3,181 | €3,181 | €168,181 | €168,181 | €168,181 | €168,181 | €168,181 | €168,181 | €168,181 | €168,181 | €168,181 | €168,181 | €168,181 | €168,181 | €168,181 | €168,181 | €168,181 | €168,181 | - | - | - | - | - | - | - | - | - | €168,181 |
This bar chart shows individual tasks ranked by their spending amounts, providing insight into which tasks require the most budget.
Showing top 30 tasks by spending amount (descending order). Labels show task IDs only.
Vall d'Hebron Clinical Study 2025
[CLN-02]HIGHClinical validation study at Hospital Universitari Vall d'Hebron
aEASI Hospital Virgen de las Nieves Study
[CLN-01]HIGHPost-Market Clinical Follow-up study for automated EASI scoring system at HVN Granada
FDA 510(k) Clearance
[CLN-03]HIGHFDA clearance process including retrospective clinical study analysis
Signature meaning
The signatures for the approval process of this document can be found in the verified commits at the repository for the QMS. As a reference, the team members who are expected to participate in this document and their roles in the approval process, as defined in Annex I Responsibility Matrix of the GP-001, are:
- Author: Team members involved
- Reviewer: JD-003, JD-004
- Approver: JD-001